Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Seven genes are highly expressed in both germ-line and hematopoietic stem cells.

Melanoma research shifted focus to immunotherapy drugs after 2010, increasing their study and citations.

Four natural compounds were found to promote hair growth effectively.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

The study suggests that hypothyroidism may cause alopecia areata.

Early regulatory T cells are crucial for normal skin pigmentation.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Innate lymphoid cells help us understand and manage allergic diseases better.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

pCLCA2 protein may help maintain skin structure and function.

The gene Ascl4 is not necessary for the development of hair, teeth, or mammary glands.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.